Adrian Rawcliffe, Adaptimmune

Being a Life Sciences Leader ›

29:14 | Mar 5th

This episode features Adrian (Ad) Rawcliffe, CEO, Adaptimmune, recipient of the Life Sciences PA 2024 Patient Impact Award. Ad shares the story behind TECELRA - the first FDA approved engineered cell...Show More